Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
BMC Psychiatry|March 19, 2016
Eosinophilic myocarditis during treatment with olanzapine - report of two possible casesTorkel Vang, Mary Rosenzweig, Christina Hedegaard Bruhn, et al.
Psychopharmacology|August 2, 2015
The cardiac safety of aripiprazole treatment in patients at high risk for torsade: a systematic review with a meta-analytic approachChristoffer Polcwiartek, Benjamin Sneider, Claus Graff, et al.
European Journal of Preventive Cardiology|April 23, 2021
Short-term prognosis of normalising serum potassium following an episode of hypokalaemia in patients with chronic heart failureMette Aldahl, Christoffer Polcwiartek, Line Davidsen, et al.
Open Heart|September 30, 2020
Higher risk of major adverse cardiac events after acute myocardial infarction in patients with schizophreniaRubina Attar, Axel Wester, Sasha Koul, et al.
Open Heart|October 2, 2020
Long-term impact of baseline anaemia on clinical outcomes following percutaneous coronary intervention in stable anginaLine Davidsen, Kristian Hay Kragholm, Mette Aldahl, et al.
BMC Psychiatry|August 24, 2021
Coronary artery calcium in patients with schizophreniaTrine Trab, Rubina Attar, Svend Eggert Jensen, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 14, 2015
Cardiac effects of sertindole and quetiapine: analysis of ECGs from a randomized double-blind study in patients with schizophreniaJimmi Nielsen, Jørgen Matz, Aurelia Mittoux, et al.
European Heart Journal|March 27, 2024
Severe mental illness: cardiovascular risk assessment and managementChristoffer Polcwiartek, Kevin O'Gallagher, Daniel J Friedman, et al.
Rheumatology (Oxford, England)|July 23, 2023
Increased risk of cardiovascular disease preceding diagnosis of incident ANCA-associated vasculitis: a Danish nationwide studyLouis Nygaard, Christoffer Polcwiartek, Karl Emil Nelveg-Kristensen, et al.
Cardiology|May 28, 2020
Time Trends in the Use of Coronary Procedures, Guideline-Based Therapy, and All-Cause Mortality following the Acute Coronary Syndrome in Patients with SchizophreniaRubina Attar, Svend Eggert Jensen, Rene Ernst Nielsen, et al.
Pageof 7